• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EDT
Click for more information
0.00% 9.1¢

EDT RETAIL TRUST - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
EDTSUSPENSION FROM OFFICIAL QUOTATION - close of trade 3/8/11PRICE SENSITIVE26/07/11
EDTFourth Supplementary Bidder's StatementPRICE SENSITIVE08/07/11
EDTResults of Unitholder MeetingPRICE SENSITIVE08/07/11
EDTTrading HaltPRICE SENSITIVE08/07/11
EDTVariation of Takeover BidPRICE SENSITIVE01/07/11
EDTThird Supplementary Bidder's Statement - EPNPRICE SENSITIVE21/06/11
EDTVariation of Takeover Bid - extension of offer periodPRICE SENSITIVE17/06/11
EDTThird Supplementary Target's StatementPRICE SENSITIVE14/06/11
EDTSecond Supplementary Target's StatementPRICE SENSITIVE02/06/11
EDTVariation of Takeover Bid - extension of offer periodPRICE SENSITIVE02/06/11
EDTVariation of Takeover Bid - extension of offer periodPRICE SENSITIVE23/05/11
EDTMarch 2011 Quarter - Media ReleasePRICE SENSITIVE20/05/11
EDTSupplementary Target's StatementPRICE SENSITIVE19/05/11
EDTSupplementary Bidder's Statement - second supplementaryPRICE SENSITIVE12/05/11
EDTVariation of Takeover Bid - increase of offer pricePRICE SENSITIVE11/05/11
EDTTarget's StatementPRICE SENSITIVE06/05/11
EDTIndependent Expert's ReportPRICE SENSITIVE03/05/11
EDTIndependent Expert's Report on EPN BidPRICE SENSITIVE27/04/11
EDTSupplementary Bidder's StatementPRICE SENSITIVE14/04/11
EDTRefinancing of Bison PortfolioPRICE SENSITIVE24/03/11
EDTOffer by EPNPRICE SENSITIVE10/03/11
EDTTrading HaltPRICE SENSITIVE08/03/11
EDTAppendix 4E and FinancialsPRICE SENSITIVE24/02/11
EDTProperty Revaluations and Date For Results PresentationPRICE SENSITIVE15/02/11
EDTNew Management TeamPRICE SENSITIVE16/12/10
EDTEstimated Distribution for 31 December 2010PRICE SENSITIVE16/12/10
EDTSeptember 2010 Quarter - Media ReleasePRICE SENSITIVE17/11/10
EDTEDT completes US$174 million refinancing to 2017PRICE SENSITIVE20/09/10
EDTAppendix 4E and Financial StatementsPRICE SENSITIVE25/08/10
EDTSingle Box Portfolio UpdatePRICE SENSITIVE10/08/10
EDTQuarterly Leasing Update and Asset RevaluationsPRICE SENSITIVE30/07/10
EDTCompletion of Revolver Facility Extension to April 2013PRICE SENSITIVE01/07/10
EDTSale of Three Former Mervyns AssetsPRICE SENSITIVE29/06/10
EDTSUSPENSION FROM OFFICIAL QUOTATION - close of trade 3/8/11
26/07/11PRICE SENSITIVE
EDTFourth Supplementary Bidder's Statement
08/07/11PRICE SENSITIVE
EDTResults of Unitholder Meeting
08/07/11PRICE SENSITIVE
EDTTrading Halt
08/07/11PRICE SENSITIVE
EDTVariation of Takeover Bid
01/07/11PRICE SENSITIVE
EDTThird Supplementary Bidder's Statement - EPN
21/06/11PRICE SENSITIVE
EDTVariation of Takeover Bid - extension of offer period
17/06/11PRICE SENSITIVE
EDTThird Supplementary Target's Statement
14/06/11PRICE SENSITIVE
EDTSecond Supplementary Target's Statement
02/06/11PRICE SENSITIVE
EDTVariation of Takeover Bid - extension of offer period
02/06/11PRICE SENSITIVE
EDTVariation of Takeover Bid - extension of offer period
23/05/11PRICE SENSITIVE
EDTMarch 2011 Quarter - Media Release
20/05/11PRICE SENSITIVE
EDTSupplementary Target's Statement
19/05/11PRICE SENSITIVE
EDTSupplementary Bidder's Statement - second supplementary
12/05/11PRICE SENSITIVE
EDTVariation of Takeover Bid - increase of offer price
11/05/11PRICE SENSITIVE
EDTTarget's Statement
06/05/11PRICE SENSITIVE
EDTIndependent Expert's Report
03/05/11PRICE SENSITIVE
EDTIndependent Expert's Report on EPN Bid
27/04/11PRICE SENSITIVE
EDTSupplementary Bidder's Statement
14/04/11PRICE SENSITIVE
EDTRefinancing of Bison Portfolio
24/03/11PRICE SENSITIVE
EDTOffer by EPN
10/03/11PRICE SENSITIVE
EDTTrading Halt
08/03/11PRICE SENSITIVE
EDTAppendix 4E and Financials
24/02/11PRICE SENSITIVE
EDTProperty Revaluations and Date For Results Presentation
15/02/11PRICE SENSITIVE
EDTNew Management Team
16/12/10PRICE SENSITIVE
EDTEstimated Distribution for 31 December 2010
16/12/10PRICE SENSITIVE
EDTSeptember 2010 Quarter - Media Release
17/11/10PRICE SENSITIVE
EDTEDT completes US$174 million refinancing to 2017
20/09/10PRICE SENSITIVE
EDTAppendix 4E and Financial Statements
25/08/10PRICE SENSITIVE
EDTSingle Box Portfolio Update
10/08/10PRICE SENSITIVE
EDTQuarterly Leasing Update and Asset Revaluations
30/07/10PRICE SENSITIVE
EDTCompletion of Revolver Facility Extension to April 2013
01/07/10PRICE SENSITIVE
EDTSale of Three Former Mervyns Assets
29/06/10PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.